- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 7 - Increased Monetary Costs of Multiple Sclerosis
During this segment, the panelists discuss the how the trend toward outpatient care and development of disease-modifying therapies for the treatment of multiple sclerosis (MS) has affected costs of care.
Leslie Fish, PharmD, explains that because most treatment options for MS are available through the pharmaceutical side, the costs of medications and entire cost of treatment for MS has risen dramatically since 2010.
Gary M. Owens, MD, agrees and explains a 3 year analysis that compared the direct medical costs of MS to pharmaceutical costs and revealed that 85% of the expenditures for the treatment of MS result on the pharmaceutical side.
Dr Fish continues by explaining how the decrease in the number of hospitalizations is relative to the trend to treat MS in an outpatient care setting.
The panelists conclude the discussion with concerns that as the treatment costs for MS continue to rise, many aspects of treatment aren’t covered, which leaves a huge burden on patients, their caregivers, and family members.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
